| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/19/2002 | WO2002072840A2 Process for the fermentative production of d-pantothenic acid |
| 09/19/2002 | WO2002072839A1 Glucose dehydrogenase |
| 09/19/2002 | WO2002072838A2 A process for the fermentative preparation of d-pantothenic acid and/or its salts |
| 09/19/2002 | WO2002072837A1 Plant synthesizing copolyester from monomer derived from short-chain fatty acid and process for producing polyester |
| 09/19/2002 | WO2002072836A2 Replication-competent molecular clones of porcine endogenous retrovirus class a and class b derived from pig and human cells |
| 09/19/2002 | WO2002072835A1 Use of flavivirus for the expression of protein epitopes and development of new live attenuated vaccine virus to immune against flavivirus and other infectious agents |
| 09/19/2002 | WO2002072834A1 Plant that is resistant to heavy metal-contaminated media |
| 09/19/2002 | WO2002072833A1 Cloning of the cdna that codes for cup s 1, the major allergen of cupressus sempervirens |
| 09/19/2002 | WO2002072832A2 Therapeutic binding molecules |
| 09/19/2002 | WO2002072831A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/19/2002 | WO2002072830A2 Proteins associated with cell growth, differentiation, and death |
| 09/19/2002 | WO2002072829A1 Novel g protein-coupled receptor protein and dna thereof |
| 09/19/2002 | WO2002072828A1 Method of predicting cancer |
| 09/19/2002 | WO2002072827A1 Traf3-binding b cell-specific receptor |
| 09/19/2002 | WO2002072826A2 Neurotrophic factors |
| 09/19/2002 | WO2002072825A2 Human mrp5-like protein |
| 09/19/2002 | WO2002072824A2 Human transient receptor potential channel protein. |
| 09/19/2002 | WO2002072823A2 Human g protein-coupled receptor |
| 09/19/2002 | WO2002072822A2 Als2 gene and amyotrophic lateral sclerosis type 2 |
| 09/19/2002 | WO2002072821A2 Method for indentification of cdnas encoding signal peptides |
| 09/19/2002 | WO2002072820A1 Transgenic cells and animals for the study of the polarization of the immune response |
| 09/19/2002 | WO2002072818A1 Genes encoding proteins participating in cytokinin synthesis |
| 09/19/2002 | WO2002072817A1 Novel protein, gene encoding the same and method of using the same |
| 09/19/2002 | WO2002072815A1 Method of aligning genomic clones |
| 09/19/2002 | WO2002072814A2 Engineered baculoviruses and their use |
| 09/19/2002 | WO2002072811A2 Human prenylcysteine lyase-like protein |
| 09/19/2002 | WO2002072808A1 Methods of screening for introduction of dna into a target cell |
| 09/19/2002 | WO2002072805A2 Thymidylate synthase |
| 09/19/2002 | WO2002072804A2 Novel genes for conditional cell ablation |
| 09/19/2002 | WO2002072803A2 Subgenomic replicons of the flavivirus dengue |
| 09/19/2002 | WO2002072802A2 Live attenuated strains of prrs virus |
| 09/19/2002 | WO2002072801A1 Method for the production of nuclear transfer embryos |
| 09/19/2002 | WO2002072794A2 Immunoglobulin superfamily proteins |
| 09/19/2002 | WO2002072790A2 Tsg101-gag interaction and use thereof |
| 09/19/2002 | WO2002072789A2 Genomics-driven high speed cellular assays, development thereof, and collections of cellular reporters |
| 09/19/2002 | WO2002072788A2 Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses |
| 09/19/2002 | WO2002072787A2 Telomerase expression repressor proteins and methods of using the same |
| 09/19/2002 | WO2002072786A2 Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon |
| 09/19/2002 | WO2002072784A2 Heat stable mutants of starch biosynthesis enzymes |
| 09/19/2002 | WO2002072783A2 Identification of cellular targets for biologically active molecules |
| 09/19/2002 | WO2002072782A2 Master activators of pathogen responsive genes |
| 09/19/2002 | WO2002072781A2 Electromanipulation device and method |
| 09/19/2002 | WO2002072778A2 Method for identifying inhibitors of g protein coupled receptor signaling |
| 09/19/2002 | WO2002072776A2 Cell culture system for synthesis of infectious hepatitis c virus |
| 09/19/2002 | WO2002072775A2 Lipid metabolism regulators in plants |
| 09/19/2002 | WO2002072774A2 Novel human transporter proteins and polynucleotides encoding the same |
| 09/19/2002 | WO2002072773A2 Methods and compositions for amplification of rna sequences |
| 09/19/2002 | WO2002072772A2 Methods and compositions for amplification of rna sequences |
| 09/19/2002 | WO2002072769A2 Human serpin polypeptides |
| 09/19/2002 | WO2002072762A2 Use of rna interference for the creation of lineage specific es and other undifferentiated cells and production of differentiated cells in vitro by co-culture |
| 09/19/2002 | WO2002072759A2 Method to screen peptide display libraries using minicell display |
| 09/19/2002 | WO2002072758A2 Cytochrome p450s and uses thereof |
| 09/19/2002 | WO2002072756A2 Feline immunodeficiency virus central dna flap |
| 09/19/2002 | WO2002072755A2 Polynucleotide encoding a novel human g-protein coupled receptor, hgprbmy27 |
| 09/19/2002 | WO2002072754A2 Mva expressing modified hiv envelope, gag, and pol genes |
| 09/19/2002 | WO2002072634A2 Recombinant proteinase k |
| 09/19/2002 | WO2002072633A1 Novel overexpressed protein in prostate cancer |
| 09/19/2002 | WO2002072632A2 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof. |
| 09/19/2002 | WO2002072630A2 Nucleic acid-associated proteins |
| 09/19/2002 | WO2002072626A2 Novel form of the phgpx protein as a diagnostic marker for male infertility |
| 09/19/2002 | WO2002072623A1 Genes and proteins, and their use |
| 09/19/2002 | WO2002072618A1 Novel peptide ligands of leukocyte integrins |
| 09/19/2002 | WO2002072616A2 Transfection complexes |
| 09/19/2002 | WO2002072611A2 Novel human egf-family proteins and polynucleotides encoding the same |
| 09/19/2002 | WO2002072608A2 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW-AFFINITY FCηRECEPTORS |
| 09/19/2002 | WO2002072607A2 Soluble heterodimeric cytokine receptor |
| 09/19/2002 | WO2002072605A2 Expression technology for proteins containing a hybrid isotype antibody moiety |
| 09/19/2002 | WO2002072603A2 Novel human dectin proteins and polynucleotides encoding the same |
| 09/19/2002 | WO2002072601A2 Apoptosis modulator bcl-b and methods for making and using same |
| 09/19/2002 | WO2002072600A2 Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections |
| 09/19/2002 | WO2002072596A1 Steap-related protein |
| 09/19/2002 | WO2002072541A2 Human grk7: new member of the human g-protein-coupled-receptor kinase family |
| 09/19/2002 | WO2002072152A1 Gene carriers with the use of polysaccharide and process for producing the same |
| 09/19/2002 | WO2002072140A2 Mhc-i-restricted presentation of hiv-1 virion antigens without viral replication. application to the stimulation of ctl and vaccination in vivo; analysis of vaccinating composition in vitro |
| 09/19/2002 | WO2002072127A2 Modulation of smooth muscle cell proliferation by vegf-x or antagonists thereof |
| 09/19/2002 | WO2002072036A2 Compositions and methods comprising west nile virus polypeptides |
| 09/19/2002 | WO2002072032A2 Compounds and methods for identifying, staging and treating cutaneous t-cell lymphoma |
| 09/19/2002 | WO2002072030A2 High affinity integrin polypeptides and uses thereof |
| 09/19/2002 | WO2002072028A2 Compositions and methods for modifying the content of polyunsaturated fatty acids in mammalian cells |
| 09/19/2002 | WO2002072027A2 Oncolytic rna replicons |
| 09/19/2002 | WO2002072024A2 Transgenic proteins from multi-gene systems, methods, compositions, uses and the like relating thereto |
| 09/19/2002 | WO2002072023A2 Production of high levels of transgenic factor viii with engineered stability, and its therapeutic uses |
| 09/19/2002 | WO2002072019A2 Interferon-beta polynucleotide therapy for autoimmune and inflammatory diseases |
| 09/19/2002 | WO2002072017A2 Method of drug target validation |
| 09/19/2002 | WO2002072015A2 M cell directed vaccines |
| 09/19/2002 | WO2002072006A2 METHODS AND REAGENTS FOR IDENTIFYING COMPOUNDS AND MUTATIONS THAT MODULATE DOPAMINE β-HYDROXYLASE ACTIVITY |
| 09/19/2002 | WO2002071843A1 Recombinant adeno-assocaited virus-mediated gene transfer via retroductal infusion of virions |
| 09/19/2002 | WO2002071834A2 Biotin-binding compounds for induction of sterility in plants |
| 09/19/2002 | WO2002059372A3 Three dimensional biochip |
| 09/19/2002 | WO2002059330A3 Artificial chromosomes comprising concatemers of expressible nucleotide sequences |
| 09/19/2002 | WO2002059269A3 Maintenance of genic male-sterile female parental lines using a maintainer line with a stable engineered chromosome |
| 09/19/2002 | WO2002057798A3 Sample processing device and method |
| 09/19/2002 | WO2002055663A3 Srebp pathway modulation through targeting hisrs |
| 09/19/2002 | WO2002055549A3 Systems for expression of heterologous proteins in m. capsulatus |
| 09/19/2002 | WO2002055532A3 Variant growth hormone molecules conjugated with macromolecular compounds |
| 09/19/2002 | WO2002050292A3 Modulation of plant cyclin-dependent kinase inhibitor activity |
| 09/19/2002 | WO2002050119A3 Method for modulating the binding activity of a novel icam-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 09/19/2002 | WO2002040696A3 Methods for large scale protein production in prokaryotes |
| 09/19/2002 | WO2002039809A3 Regulation of flavonoid expression in alfalfa using maize regulatory genes |
| 09/19/2002 | WO2002036620A9 Ets-transcription factor related compound specific promoter and transactivators thereof |